154 related articles for article (PubMed ID: 22226267)
1. The ASPIRE study: design and methods of an in-clinic crossover trial on the efficacy of automatic insulin pump suspension in exercise-induced hypoglycemia.
Brazg RL; Bailey TS; Garg S; Buckingham BA; Slover RH; Klonoff DC; Nguyen X; Shin J; Welsh JB; Lee SW
J Diabetes Sci Technol; 2011 Nov; 5(6):1466-71. PubMed ID: 22226267
[TBL] [Abstract][Full Text] [Related]
2. Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study.
Garg S; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
Diabetes Technol Ther; 2012 Mar; 14(3):205-9. PubMed ID: 22316089
[TBL] [Abstract][Full Text] [Related]
3. The PILGRIM study: in silico modeling of a predictive low glucose management system and feasibility in youth with type 1 diabetes during exercise.
Danne T; Tsioli C; Kordonouri O; Blaesig S; Remus K; Roy A; Keenan B; Lee SW; Kaufman FR
Diabetes Technol Ther; 2014 Jun; 16(6):338-47. PubMed ID: 24447074
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of a Predictive Low-Glucose Management System In-Clinic.
Buckingham BA; Bailey TS; Christiansen M; Garg S; Weinzimer S; Bode B; Anderson SM; Brazg R; Ly TT; Kaufman FR
Diabetes Technol Ther; 2017 May; 19(5):288-292. PubMed ID: 28221823
[TBL] [Abstract][Full Text] [Related]
5. ASPIRE In-Home: rationale, design, and methods of a study to evaluate the safety and efficacy of automatic insulin suspension for nocturnal hypoglycemia.
Klonoff DC; Bergenstal RM; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann A; Welsh JB; Lee SW
J Diabetes Sci Technol; 2013 Jul; 7(4):1005-10. PubMed ID: 23911183
[TBL] [Abstract][Full Text] [Related]
6. In-Clinic Evaluation of the MiniMed 670G System "Suspend Before Low" Feature in Children with Type 1 Diabetes.
Wood MA; Shulman DI; Forlenza GP; Bode BW; Pinhas-Hamiel O; Buckingham BA; Kaiserman KB; Liljenquist DR; Bailey TS; Shin J; Huang S; Chen X; Cordero TL; Lee SW; Kaufman FR
Diabetes Technol Ther; 2018 Nov; 20(11):731-737. PubMed ID: 30299976
[TBL] [Abstract][Full Text] [Related]
7. Hypoglycemic Accuracy and Improved Low Glucose Alerts of the Latest Dexcom G4 Platinum Continuous Glucose Monitoring System.
Peyser TA; Nakamura K; Price D; Bohnett LC; Hirsch IB; Balo A
Diabetes Technol Ther; 2015 Aug; 17(8):548-54. PubMed ID: 25961446
[TBL] [Abstract][Full Text] [Related]
8. Effectiveness of the low-glucose suspend feature of insulin pump during fasting during Ramadan in type 1 diabetes mellitus.
Elbarbary NS
Diabetes Metab Res Rev; 2016 Sep; 32(6):623-33. PubMed ID: 26789012
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of a Predictive Algorithm in the Prevention of Exercise-Induced Hypoglycemia in Type 1 Diabetes.
Abraham MB; Davey R; O'Grady MJ; Ly TT; Paramalingam N; Fournier PA; Roy A; Grosman B; Kurtz N; Fairchild JM; King BR; Ambler GR; Cameron F; Jones TW; Davis EA
Diabetes Technol Ther; 2016 Sep; 18(9):543-50. PubMed ID: 27505305
[TBL] [Abstract][Full Text] [Related]
10. Hypoglycemia begets hypoglycemia: the order effect in the ASPIRE in-clinic study.
Garg SK; Brazg RL; Bailey TS; Buckingham BA; Slover RH; Klonoff DC; Shin J; Welsh JB; Kaufman FR
Diabetes Technol Ther; 2014 Mar; 16(3):125-30. PubMed ID: 24405492
[TBL] [Abstract][Full Text] [Related]
11. Predictive Low-Glucose Suspend Reduces Hypoglycemia in Adults, Adolescents, and Children With Type 1 Diabetes in an At-Home Randomized Crossover Study: Results of the PROLOG Trial.
Forlenza GP; Li Z; Buckingham BA; Pinsker JE; Cengiz E; Wadwa RP; Ekhlaspour L; Church MM; Weinzimer SA; Jost E; Marcal T; Andre C; Carria L; Swanson V; Lum JW; Kollman C; Woodall W; Beck RW
Diabetes Care; 2018 Oct; 41(10):2155-2161. PubMed ID: 30089663
[TBL] [Abstract][Full Text] [Related]
12. "Let the Algorithm Do the Work": Reduction of Hypoglycemia Using Sensor-Augmented Pump Therapy with Predictive Insulin Suspension (SmartGuard) in Pediatric Type 1 Diabetes Patients.
Biester T; Kordonouri O; Holder M; Remus K; Kieninger-Baum D; Wadien T; Danne T
Diabetes Technol Ther; 2017 Mar; 19(3):173-182. PubMed ID: 28099035
[TBL] [Abstract][Full Text] [Related]
13. Usage and effectiveness of the low glucose suspend feature of the Medtronic Paradigm Veo insulin pump.
Agrawal P; Welsh JB; Kannard B; Askari S; Yang Q; Kaufman FR
J Diabetes Sci Technol; 2011 Sep; 5(5):1137-41. PubMed ID: 22027306
[TBL] [Abstract][Full Text] [Related]
14. Fear of hypoglycemia in children with type 1 diabetes and their parents: Effect of pump therapy and continuous glucose monitoring with option of low glucose suspend in the CGM TIME trial.
Verbeeten KC; Perez Trejo ME; Tang K; Chan J; Courtney JM; Bradley BJ; McAssey K; Clarson C; Kirsch S; Curtis JR; Mahmud FH; Richardson C; Cooper T; Lawson ML;
Pediatr Diabetes; 2021 Mar; 22(2):288-293. PubMed ID: 33179818
[TBL] [Abstract][Full Text] [Related]
15. Glycemia, Treatment Satisfaction, Cognition, and Sleep Quality in Adults and Adolescents with Type 1 Diabetes When Using a Closed-Loop System Overnight Versus Sensor-Augmented Pump with Low-Glucose Suspend Function: A Randomized Crossover Study.
Sharifi A; De Bock MI; Jayawardene D; Loh MM; Horsburgh JC; Berthold CL; Paramalingam N; Bach LA; Colman PG; Davis EA; Grosman B; Hendrieckx C; Jenkins AJ; Kumareswaran K; Kurtz N; Kyoong A; MacIsaac RJ; Speight J; Trawley S; Ward GM; Roy A; Jones TW; O'Neal DN
Diabetes Technol Ther; 2016 Dec; 18(12):772-783. PubMed ID: 27835037
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of sensor-augmented pump therapy (SAPT) with predictive low-glucose management in patients diagnosed with type 1 diabetes mellitus previously treated with SAPT and low glucose suspend.
Gómez AM; Henao DC; Imitola A; Muñoz OM; Sepúlveda MAR; Kattah L; Guerrero JS; Morros E; Llano JP; Jaramillo MG; León-Vargas F
Endocrinol Diabetes Nutr (Engl Ed); 2018 Oct; 65(8):451-457. PubMed ID: 29914817
[TBL] [Abstract][Full Text] [Related]
17. Threshold-based insulin-pump interruption for reduction of hypoglycemia.
Bergenstal RM; Klonoff DC; Garg SK; Bode BW; Meredith M; Slover RH; Ahmann AJ; Welsh JB; Lee SW; Kaufman FR;
N Engl J Med; 2013 Jul; 369(3):224-32. PubMed ID: 23789889
[TBL] [Abstract][Full Text] [Related]
18. Analysis of glucose responses to automated insulin suspension with sensor-augmented pump therapy.
Ly TT; Nicholas JA; Retterath A; Davis EA; Jones TW
Diabetes Care; 2012 Jul; 35(7):1462-5. PubMed ID: 22584133
[TBL] [Abstract][Full Text] [Related]
19. The impact of accelerometer use in exercise-associated hypoglycemia prevention in type 1 diabetes.
Stenerson M; Cameron F; Payne SR; Payne SL; Ly TT; Wilson DM; Buckingham BA
J Diabetes Sci Technol; 2015 Jan; 9(1):80-5. PubMed ID: 25231116
[TBL] [Abstract][Full Text] [Related]
20. Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy.
Danne T; Kordonouri O; Holder M; Haberland H; Golembowski S; Remus K; Bläsig S; Wadien T; Zierow S; Hartmann R; Thomas A
Diabetes Technol Ther; 2011 Nov; 13(11):1129-34. PubMed ID: 21827318
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
